the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

US Navy ships’ Penang stop was routine and approved

The recent US Navy vessels’ stop in Penang was a routine, government-approved port call for logistics and crew rest, says Defence Minister.

KUALA LUMPUR: The recent presence of two United States Navy vessels in Penang was a routine port of call for logistical purposes that had received official approval from the Malaysian government.

Defence Minister Datuk Seri Mohamed Khaled Nordin said USS Santa Barbara and USS Tulsa docked at the North Butterworth Container Terminal from March 14 to 16.

He said the stopover enabled the vessels to carry out replenishment, maintenance and provide rest for crew members before continuing their voyage.

“Port of call visits by foreign naval vessels at Malaysian ports are not new and have long been part of established international defence relations.”

Mohamed Khaled added that Malaysia has clear procedures where every docking request must go through official channels and is subject to government approval.

He said such visits are part of efforts to enhance confidence-building measures while safeguarding the country’s sovereignty and territorial integrity.

The practice is also in line with the Defence White Paper to ensure regional stability and global peace.

Malaysia received a total of 75 visits by foreign naval vessels from 14 countries throughout 2025.

Among the countries that have made port calls in Malaysia are Australia, China, the United Kingdom, Japan, France, Indonesia, Singapore and the United States.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings